Emergent BioSolutions Inc. Form 4 (Feb. 8, 2021)

Summary

This Emergent BioSolutions Inc. [EBS] Form 4 reports that Kramer Robert, a director and officer with the title President and CEO, exercised and sold option shares on February 8, 2021, under a trading plan adopted on November 13, 2020. The reporting person exercised 32,397 Employee Stock Options (Right to Buy) granted on 3/1/2016 at $30.86 and 13,000 options granted on 2/28/2017 at $30.63, selling each block at a weighted average price of $120.03. After the sales the reporting person owned 139,210 shares directly and 19,638 options from the 2/28/2017 grant. The form is signed /s/ S. Scott Lieberman, Attorney-in-fact, on February 9, 2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Kramer Robert (Last) (First) (Middle) 400 PROFESSIONAL DR, SUITE 400 (Street) GAITHERSBURG MD 20879 (City) (State) (Zip) | Kramer Robert | (Last) | (First) | (Middle) | 400 PROFESSIONAL DR, SUITE 400 | GAITHERSBURG | MD | 20879 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Emergent BioSolutions Inc. [ EBS ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) President and CEO | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | President and CEO
3. Date of Earliest Transaction
 (Month/Day/Year) 02/08/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock (1) | 02/08/2021 | M (2) | 32,397 | A | $ 30.86 | 171,607 | D
Common Stock (1) | 02/08/2021 | S (2) | 32,397 | D | $ 120.03 (3) | 139,210 | D
Common Stock (4) | 02/08/2021 | M (2) | 13,000 | A | $ 30.63 | 152,210 | D
Common Stock (4) | 02/08/2021 | S (2) | 13,000 | D | $ 120.03 (5) | 139,210 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Employee Stock Options (Right to Buy) (1) | $ 30.86 | 02/08/2021 | M (2) | 32,397 | (6) | 02/28/2023 | Common Stock | 32,397 | $ 120.03 (3) | 0 | D
Employee Stock Options (Right to Buy) (4) | $ 30.63 | 02/08/2021 | M (2) | 13,000 | (6) | 02/27/2024 | Common Stock | 13,000 | $ 120.03 (5) | 19,638 | D
Explanation of Responses:
1. Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated.
2. All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
3. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20.
4. Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated.
5. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.19.
6. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Remarks:
/s/ S. Scott Lieberman, Attorney-in-fact | 02/09/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_EBS_4_filed2021-02-09_0001367644-21-000008.xml

Size

20,754 bytes

SHA-256

c0da7b8262d445a1b252913c7b9fbbf9abaa7c0b9cc69a1e9127d74318b8e159

Our copy

SEC_EBS_4_filed2021-02-09_0001367644-21-000008.xml

Original

www.sec.gov